TRML

Tourmaline Bio

• Reuters·01/21 15:38

  BUZZ-Zura Bio names new CEO; shares rise

• Benzinga·10/29/2025 13:54

  Cantor Fitzgerald Suspends Overweight Rating on Tourmaline Bio

• Simply Wall St·10/29/2025 02:19

  Tourmaline Bio (TRML): Evaluating Valuation After Recent Strong Share Price Gains

• Reuters·10/28/2025 16:13

  Tourmaline Bio Inc. Files Initial Beneficial Ownership Statement Naming Novartis AG

• TipRanks·10/28/2025 14:58

  Tourmaline Bio to Delist from Nasdaq and Deregister

• Reuters·10/28/2025 14:43

  Tourmaline Bio Inc. Completes Merger and Terminates $100 Million ATM Sales Agreement

• TipRanks·10/28/2025 14:10

  Tourmaline Bio acquisition completed by Novartis

• Reuters·10/28/2025 13:52

  NOVARTIS AG - WITH COMPLETION OF ACQUISITION, SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE ( "SHARES")

• Seeking Alpha·10/28/2025 08:13

  Novartis Q3 profit swells as oncology drugs drive growth

• Reuters·10/28/2025 06:26

  BRIEF-Novartis Announces Expiration Of Tourmaline Bio Tender Offer

• TipRanks·10/27/2025 19:52

  Tourmaline Bio’s Promising Phase 2b Study on Thyroid Eye Disease Treatment

• Seeking Alpha·10/25/2025 15:00

  Microsoft, Meta Set To Report Earnings As Investors Watch Out For Trump-Xi, Fed Meeting

• Seeking Alpha·10/24/2025 19:00

  Catalyst Watch: Trump-Xi, Fed meeting, Honeywell spinoff, and Amazon headlines busy earnings week

• TipRanks·10/22/2025 11:06

  Novartis announces expiration of HSR Act waiting period of Tourmaline Bio offer

• Seeking Alpha·10/04/2025 15:00

  PepsiCo, Levi Strauss Set To Report Earnings